410 IAC 1-2.5-121 Novel influenza A; specific control measures

Sec. 121. The specific control measures for novel influenza A (infectious agent: novel influenza A virus) are as follows: (1) An investigation by the local health officer shall be performed within twenty-four (24) hours. (2) Standard precautions are required for hospitalized patients. Respiratory protection that is at least as protective as a fit-tested N95 respirator for health care personnel who are in close contact with patients with suspect or confirmed novel influenza A is recommended. This recommendation may change after there has been adequate time to assess the recommendation, and the Centers for Disease Control and Prevention will continue to revisit its guidance as new information and sufficient supplies become available. (3) Concurrent disinfection is required. (4) Quarantine is not required. (5) Immunization is not available. Protection of contacts is not applicable. (6) The Centers for Disease Control and Prevention and the Council of State and Territorial Epidemiologists set the standard clinical and laboratory case definition.